• Disrupting or Preventing Formation of Biofilm by Enzyme Inhibitors (No. T4-1893)

    Biofilm is a complex colony of bacteria, which are attached together by extracellular polymeric substance. This setting provides the bacteria protection against environmental factors, improves their surface attachment, and plays a major role in resistance to treatment. ... Read more
    Senior Scientist ILANA Kolodkin-Gal

    ILANA Kolodkin-Gal

    Faculty of Biochemistry

  • Universal CAR-Ts (No. T4-1884)

    Chimeric Antigen Receptor T-Cells (CAR-Ts) are one of the revolutionary technologies of the twenty-first century, invented by Prof. Zelig Eshhar at the Weizmann Institute of Science. ... Read more
    Emeritus Zelig Eshhar

    Zelig Eshhar

    Faculty of Biology

  • Inhibiting Importin to Treat Psychiatric Stress and Other Disorders (No. T4-1875)

    Anxiety and stress-related conditions pose a significant health burden on modern healthcare systems. While currently, available anxiolytic drugs can be highly effective for some patients, their long-term use is limited by their potentially severe and debilitating side effects. The group of Prof. ... Read more
    Full Professor Michael Fainzilber

    Michael Fainzilber

    Faculty of Biochemistry

  • A Method in Improving Survival and Expansion of Hematopoietic Stem Cells (No. T4-1874)

    hematopoietic cells. HSCs have the capacity to both self-renew and to differentiate, and they migrate from the bone marrow to the blood upon demand. Since HSCs can differentiate to a variety of cell types, including immune system cells, they have a huge therapeutic potential. ... Read more
    Full Professor Idit Shachar

    Idit Shachar

    Faculty of Biology

  • Novel Method for Diagnosis and Treating Cancer by Analyzing the Urea Cycle (No. T4-1872)

    The urea cycle (UC) is an important metabolic pathway that takes place in the liver. A variety of enzymes, such as argininosuccinate synthase 1 (ASS1) and the trifunctional enzyme CAD, are involved in the UC, which converts excess nitrogen into urea. ... Read more
    Associate Professor Ayelet EREZ

    Ayelet EREZ

    Faculty of Biology

  • Novel Treatment for Lung Diseases by Allogeneic Cell Transplantation (No. T4-1868)

    The treatment of respiratory conditions is currently one of the major challenges to health care systems all over the world. The problem is that most therapeutics currently available for treating pulmonary indications are non-curative, and simply improve symptoms. ... Read more
    Emeritus Yair Reisner

    Yair Reisner

    Faculty of Biology

  • Arbitrium - A Novel Approach for Controlling Gene Expression (No. T4-1847)

    One of the challenges in the areas of synthetic biology and its clinical applications, is the capacity to control the induction of different genes, whether for the purpose of activating genetic circuits or inducing the expression of a specific protein. ... Read more
    Full Professor Rotem Sorek

    Rotem Sorek

    Faculty of Biochemistry

  • Methods for High-Throughput Analysis of Transcriptomes (No. T4-1843)

    Analysis of the transcriptome of cells can inform greatly about the state of said cells, including maturation, activation, transformation, etc. ... Read more
    Associate Professor Ido Amit

    Ido Amit

    Faculty of Biology

  • A Novel Method for Detecting Activation of Necroptosis via Exosome Analysis (No. T4-1839)

    Numerous medical conditions are related to inflammation, such as pancreatitis, psoriasis, inflammatory bowel disease, atherosclerosis, neurodegeneration, and more. However, determination of inflammation in the body, especially at early stages of a pathology is difficult to assess. ... Read more
    Emeritus David Wallach

    David Wallach

    Faculty of Biochemistry

  • A Novel Technique to Produce Large Quantities of Therapeutic T cells (No. T4-1810)

    Production of large quantities of T cells is an essential demand for the development of immunotherapies. However, ex-vivo culturing of T-cells is very inefficient, resulting in high cell death rates. ... Read more
    Associate Professor Nir FRIEDMAN





Subscribe to Pharmaceuticals